TECNOLOGÍA PARA LA MONITORIZACIÓN Y CONTROL DE LA DIABETES

VolverVolver

Resultados 139 resultados LastUpdate Última actualización 26/11/2022 [11:56:00] pdf PDF xls XLS

Solicitudes publicadas en los últimos 60 días / Applications published in the last 60 days



Página1 de 6 nextPage   por página


METHOD FOR CALIBRATING NON-INVASIVE BIOMETRIC INFORMATION

NºPublicación: WO2022244963A1 24/11/2022

Solicitante:

I SENS INC [KR]

Resumen de: WO2022244963A1

The present invention relates to a method for calibrating non-invasive biometric information measured by a non-invasive biometric information measurement apparatus, and more specifically to a method for calibrating non-invasive biometric information, wherein non-invasive biometric information measured by a non-invasive blood glucose meter can be learned using continuous biometric information measured by a continuous blood glucose meter, and thereby calibrated so as to be personalized to a user, and by using the continuous biometric information, measured by the continuous blood glucose meter to calibrate uncertain non-invasive biometric information measured by the non-invasive blood glucose meter so as to be personalized to the user, the pattern of increase/decrease in user biometric information can be accurately determined from the still uncertain non-invasive biometric information.

traducir

DATA-STREAM BRIDGING FOR SENSOR TRANSITIONS

NºPublicación: WO2022245763A1 24/11/2022

Solicitante:

DEXCOM INC [US]

US_2022361778_PA

Resumen de: WO2022245763A1

Data-stream bridging for sensor transitions is described. A first data stream of glucose measurements is received from a first glucose sensor worn by a user. A termination event for the first glucose sensor is detected when production and/or communication of the first glucose measurements via the first data stream ceases. Next, a second data stream of glucose measurements is received from a second glucose sensor worn by the user that replaces the first glucose sensor. During a warmup period for the second glucose sensor, estimated glucose values are output for the user based on both the first data stream of glucose measurements received from the first glucose sensor prior to the termination event and the second data stream of glucose measurements received from the second glucose sensor.

traducir

A BLOOD GLUCOSE MONITORING DEVICE AND SYSTEM

NºPublicación: US2022369962A1 24/11/2022

Solicitante:

JIAXING SUMMED MEDTECH CO LTD [CN]

EP_4050335_PA

Resumen de: US2022369962A1

A blood glucose detection device and system are portable blood glucose detection devices for patients. The blood glucose detection device includes a plurality of lancing units, which collect patient blood and generate current. The test unit can detect the current and transmit the current intensity data to the external device, thus making the glucose detection device portable. Besides, there is no need to change test strips every time for a blood glucose test as the current intensity data can be transmitted externally for management, which improves the patient's experience and makes it convenient for patients to perform blood glucose tests when they go out.

traducir

DETECTION OF CHANGES IN PATIENT HEALTH BASED ON GLUCOSE DATA

NºPublicación: US2022369961A1 24/11/2022

Solicitante:

MEDTRONIC INC [US]

Resumen de: US2022369961A1

This disclosure is directed to systems and techniques for detecting change in patient health based upon patient data. In one example, a medical system comprising processing circuitry communicably coupled to a glucose sensor and configured to generate continuous glucose sensor measurements of a patient. The processing circuitry is further configured to: extract at least one feature from the continuous glucose sensor measurements over at least one time period, wherein the at least one feature comprises one or more of an amount of time within a pre-determined glucose level range, a number of hypoglycemia events, a number of hyperglycemia events, or one or more statistical metrics corresponding to the continuous glucose sensor measurements; apply a machine learning model to the at least one extracted feature to produce data indicative of a risk of a cardiovascular event; and generate output data based on the risk of the cardiovascular event.

traducir

METHOD AND DEVICE FOR LIVING TISSUE SPECTROSCOPY

NºPublicación: US2022369958A1 24/11/2022

Solicitante:

MUSIN RAMIL FARITOVICH [RU]

CN_115135240_A

Resumen de: US2022369958A1

The present group of inventions relates to medicine and medical technology, more particularly to non-invasive methods and devices for monitoring blood glucose level based on absorption isothermal calorimetric spectroscopy, which allows the content of biochemical components in living tissue to be determined in real time. The present invention also relates to methods for producing a biopolymer molecule with given biological properties and a given three-dimensional structure. The use of the group of inventions makes it possible to carry out non-invasive monitoring of the blood sugar level of patients with diabetes, including for the purpose of early diagnosis of diabetes mellitus.

traducir

SANITARY DEVICE FOR URINE GLUCOSE TEST

NºPublicación: US2022369980A1 24/11/2022

Solicitante:

TAIWAN REDEYE BIOMEDICAL INC [TW]

Resumen de: US2022369980A1

A sanitary device for the urine glucose test includes a urine container formed on an inner wall of a main body, and a measuring module with an inner space mounted at a bottom of the urine container. Within the inner space, a lens attaches to the bottom of the urine container, a rail faces a bottom surface of the lens, and a driving module moves a light unit shooting a detection beam to a measuring surface of the lens along the rail. The measuring surface contacts urine in the urine container, and reflects the detection beam out of the bottom surface into a sensor. The sensor is electrically connected to a processor. The processor determines a urine glucose level and generates a urine glucose level data instantly from an angle of incidence of the detection beam on the measuring surface and from a beam intensity signal from the sensor.

traducir

PROCESS FOR MANAGING OR ASSISTING IN THE MONITORING OF A PHYSIOLOGICAL PARAMETER OF AN INDIVIDUAL, IN PARTICULAR THE BLOOD SUGAR LEVEL

NºPublicación: US2022369960A1 24/11/2022

Solicitante:

DOCTEGESTIO [FR]

WO_2020002582_PA

Resumen de: US2022369960A1

A method for assisting in the control of a blood glucose-type physiological parameter of an individual, including the steps of prior real-time recording in the database of information relating to an insulin dose adaptation protocol, this protocol being specific to the individual, collecting a value for the physiological parameter at a given time and recording the value for the parameter in a database, recording in the database of values collected for the physiological parameter at different moments in time, optionally, recording in the database of data items relating to the individual's nutrition and/or physical activity, geolocation of the individual, and processing of information to automatically calculate at least one insulin dose.

traducir

MODEL BASED VARIABLE RISK FALSE GLUCOSE THRESHOLD ALARM PREVENTION MECHANISM

NºPublicación: US2022370021A1 24/11/2022

Solicitante:

ABBOTT DIABETES CARE INC [US]

US_2018192963_A1

Resumen de: US2022370021A1

Methods of determining when to activate an analyte, e.g. glucose, related alarm, such as a hypoglycemia alarm, of a continuous analyte monitor is provided. Also provided are systems, devices and kits.

traducir

SYSTEMS AND METHODS FOR DISPLAYING PATIENT DATA

NºPublicación: US2022375558A1 24/11/2022

Solicitante:

ELI LILLY AND COMPANY [US]

CN_114730627_PA

Resumen de: US2022375558A1

Systems, devices, and methods are provided for displaying selected patient data on a display screen of a computing device. The systems/devices/methods are configured to display on the display screen a plurality of panels, each panel displaying one or more glucose measurements for a patient recorded at different time periods. User input may be received selecting at least one of a plurality of glucose events and at least one of a plurality of contextual factors. In response, the systems/devices/methods may be further configured to display a subset of panels that exhibit each of the selected glucose events and each of the selected contextual factors.

traducir

SYSTEM, METHOD AND ARTICLE FOR CONTROLLING THE DISPENSING OF INSULIN

NºPublicación: US2022375566A1 24/11/2022

Solicitante:

DEXCOM INC [US]

US_2021016001_A1

Resumen de: US2022375566A1

An integrated circuit includes circuitry to control a process. The process includes adjusting fuzzy-logic control parameters based on received and retrieved blood glucose-related data, predicting blood glucose levels based on the received blood-glucose-related data, and generating control signals to control dispensing of insulin based on the received blood glucose-related data and the fuzzy-logic control parameters. The process may include predicting blood glucose levels based on the retrieved blood glucose-related data. The process may include transitioning between a post-meal correction protocol and a fasting protocol. The process may include transitioning from a post-meal correction protocol to a fasting protocol when a fasting criteria is satisfied.

traducir

System and method for providing alerts optimized for a user

NºPublicación: AU2022256146A1 24/11/2022

Solicitante:

DEXCOM INC [US]

CN_115177241_PA

Resumen de: AU2022256146A1

Systems and methods are disclosed that provide smart alerts to users, e.g., alerts to users about diabetic states that are only provided when it makes sense to do so, e.g., when the system can predict or estimate that the user is not already cognitively aware of their current condition, e.g., particularly where the current condition is a diabetic state warranting attention. In this way, the alert or alarm is personalized and made particularly effective for that user. Such systems and methods still alert the user when action is necessary, e.g., a bolus or temporary basal rate change, or provide a response to a missed bolus or a need for correction, but do not alert when action is unnecessary, e.g., if the user is already estimated or predicted to be cognitively aware of the diabetic state warranting attention, or if corrective action was already taken.

traducir

Population malady identification with a wearable glucose monitoring device

NºPublicación: AU2021318950A1 24/11/2022

Solicitante:

DEXCOM INC

WO_2022026422_A1

Resumen de: AU2021318950A1

Population malady identification with a wearable glucose monitoring device is described. A malady identification system obtains temperature measurements that are produced by wearable glucose monitoring devices worn by users of a user population. The malady identification system further obtains location data describing locations of the users and associates each of the temperature measurements with a respective location. The malady identification system utilizes identification logic (e.g., one or more machine learning models) to identify presence of a malady in the users at one or more of the locations based on the temperature measurements and the location data. The malady identification system generates a communication for notifying at least one of the users about the presence of the malady.

traducir

DETECTION OF CHANGES IN PATIENT HEALTH BASED ON GLUCOSE DATA

NºPublicación: WO2022245804A1 24/11/2022

Solicitante:

MEDTRONIC INC [US]

Resumen de: WO2022245804A1

This disclosure is directed to systems and techniques for detecting change in patient health based upon patient data. In one example, a medical system comprising processing circuitry communicably coupled to a glucose sensor and configured to generate continuous glucose sensor measurements of a patient. The processing circuitry is further configured to: extract at least one feature from the continuous glucose sensor measurements over at least one time period, wherein the at least one feature comprises one or more of an amount of time within a pre-determined glucose level range, a number of hypoglycemia events, a number of hyperglycemia events, or one or more statistical metrics corresponding to the continuous glucose sensor measurements; apply a machine learning model to the at least one extracted feature to produce data indicative of a risk of a cardiovascular event; and generate output data based on the risk of the cardiovascular event.

traducir

USING CONTINUOUS BIOMETRIC INFORMATION MONITORING FOR SECURITY

NºPublicación: WO2022245609A1 24/11/2022

Solicitante:

DEXCOM INC [US]

US_2022366027_PA

Resumen de: WO2022245609A1

Measurements of biometric information of a user are obtained over time, such as blood glucose measurements. These biometric measurements are typically obtained by a wearable biometric information monitoring device being worn by the user. These biometric measurements are used by various different systems, such as a computing device of the user or a biometric information monitoring platform that receives biometric measurements from multiple different users. The biometric measurements are used for various security aspects, such as one or more of part of multi-factor authentication of the user, generating security keys (e.g., connection keys, encryption keys), identifying biometric measurements associated with different user identifiers but the same use, and protecting biometric measurements so as to be retrievable only by a recipient associated with an additional computing device, and so forth.

traducir

ADAPTIVE SYSTEMS FOR CONTINUOUS GLUCOSE MONITORING

NºPublicación: WO2022245860A1 24/11/2022

Solicitante:

DEXCOM INC [US]

Resumen de: WO2022245860A1

In implementations of adaptive systems for continuous glucose monitoring (CGM), a computing device implements an adaptive system to receive glucose data describing user glucose values measured by a sensor of a CGM system, the sensor is inserted at an insertion site. The adaptive system accesses orientation data describing forces measured by an accelerometer of the CGM system, and the adaptive system identifies a location of the insertion site based on the orientation data. Modified glucose data is generated by modifying the user glucose values based on the location of the insertion site. The adaptive system generates an indication of the modified glucose data for display in a user interface of a display device.

traducir

PERIPHERAL BLOOD SAMPLING APPARATUS AND CONTROL METHOD AND CONTROL APPARATUS THEREFOR, AND STORAGE MEDIUM

NºPublicación: WO2022242318A1 24/11/2022

Solicitante:

HUBEI UNIV OF ARTS AND SCIENCE [CN]
QINGYAN NEW ENERGY VEHICLE ENG CENTER XIANGYANG CO LTD [CN]

CN_113229814_A

Resumen de: WO2022242318A1

A peripheral blood sampling apparatus (100) and a control method and control apparatus therefor, and a storage medium. The peripheral blood sampling apparatus (100) comprises a needle box, a bloodletting pricking mechanism, a driving mechanism and a distance measurement apparatus. The bloodletting pricking mechanism comprises a lancet (102), and the driving mechanism is used for driving the lancet (102) to translate. The control method for the peripheral blood sampling apparatus (100) comprises the following steps: on the basis of a distance measurement apparatus, acquiring a distance parameter L from a lancet (102) to a surface of a human body (S10); and when the distance parameter L is equal to a first distance preset value M1, controlling a driving mechanism to drive the lancet (102) to translate forward. Automatic removal and installation of the lancet (102) can be achieved, thereby omitting the operation of manually removing or installing a needle, reducing the time for which a patient waits for the removal and installation of a needle, and improving the working efficiency of blood glucose testing, bloodletting and blood type identification. Moreover, by means of an unmanned and automatic operation, the operation risk of manual replacement of the lancet (102) can be reduced, thereby avoiding potential medical hazards during blood glucose testing, bloodletting and blood type identification processes.

traducir

OFFLINE GLUCOSE CONTROL BASED ON PRECEDING PERIODS

NºPublicación: EP4091541A1 23/11/2022

Solicitante:

UNIV BOSTON [US]

MX_2020004660_A

Resumen de: EP4091541A1

Apparatus and methods calculate and deliver doses of insulin and optionally glucagon into a subject. Online operation controls delivery of correction doses of insulin automatically in response to regular glucose measurements from a sensor, and offline operation calculates and delivers correction doses based on isolated glucose measurements and information gathered autonomously during preceding online operation. In another aspect, offline operation includes automatically calculating and administering meal doses based on information gathered autonomously during preceding periods of online operation. Both methods include generating relevant control parameters tailored to the individual and continually converged upon and potentially modulated during online operation. The control parameters are employed in real time during periods of offline operation to regulate glucose level without the need for user-provided control parameters such as correction factors and insulin-to-carbohydrate ratios.

traducir

NOTIFICATION METHOD FOR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEM

NºPublicación: US2022361825A1 17/11/2022

Solicitante:

I SENS INC [KR]

JP_2022542678_PA

Resumen de: US2022361825A1

The present disclosure relates to a notification method of a continuous glucose monitoring system. A notification method of a continuous glucose monitoring system, according to one embodiment of the present invention, may comprise the steps of: performing a communication connection between a body attachment unit and a communication terminal for the communication terminal to receive blood glucose data measured from the body attachment unit which is attached to a human body and continuously measures blood glucose; transmitting information on the body attachment unit from the body attachment unit to the communication terminal and calculating a remaining use period of the body attachment unit; and generating, in the communication terminal, a notification on the remaining use period of the body attachment unit. According to the present disclosure, as the notification for the remaining period of the body attachment unit is generated in the communication terminal, there is an effect wherein a user can prepare in advance a body attachment unit to be replaced before the use period of the body attachment unit ends.

traducir

AMBULATORY MEDICAMENT DEVICE WITH MOTION DETECTION AND GESTURE-BASED CONTROL

NºPublicación: US2022362466A1 17/11/2022

Solicitante:

BETA BIONICS INC [US]

US_2022265928_PA

Resumen de: US2022362466A1

Ambulatory medicament devices that provide therapy to a subject, such as blood glucose control, are disclosed. Disclosed systems and methods can implement one or more features that improve the user experience, by modifying delivery of therapy to a subject after determining that a possible occlusion exists in a medicament delivery system, monitoring the status of an ambulatory medical device and the health condition of a subject that receives therapy from the ambulatory medical device and annunciating alarm condition when necessary, selectively muting alarm annunciations while a Do Not Disturb mode is activated, implementing various power saving modes to save power, controlling operation of the device and medicament delivery based on the user gesture controls, and controlling medicament delivery based on a condition of the ambulatory medicament device.

traducir

Analyte Monitoring System and Methods

NºPublicación: US2022361756A1 17/11/2022

Solicitante:

ABBOTT DIABETES CARE INC [US]

US_2021169327_A1

Resumen de: US2022361756A1

Disclosed embodiments include methods and systems including a receiver unit of a glucose monitoring system. The receiver is configured for communicating with a remote transmitter unit coupled with a glucose sensor. The glucose sensor generates data signals associated with a glucose level. The receiver unit includes a processor, a display, and a memory for storing instructions which, when executed by the processor: access a transmitter key associated with the remote transmitter unit; transmit a command to the remote transmitter unit after verifying the transmitter key; receive communication packets from the remote transmitter unit including a first data segment with data signals indicative of the glucose level and a second data segment with information corresponding to a remaining life of the remote transmitter unit; estimate a remaining life of the remote transmitter unit; process the data signals; and output the estimated remaining life and the processed data signals for display.

traducir

GLUCOSE PREDICTION SYSTEMS AND ASSOCIATED METHODS

NºPublicación: US2022361780A1 17/11/2022

Solicitante:

TEXAS A & M UNIV SYS [US]
BAYLOR COLLEGE MEDICINE [US]

WO_2021076984_A1

Resumen de: US2022361780A1

A method for predicting a hypoglycemic event or a hyperglycemic event includes (a) collecting one or more data streams, wherein at least one of the one or more data streams includes a glucose (GL) data stream corresponding to a user, (b) determining one or more features based on the one or more collected data streams, wherein at least one of the one or more features is distinct from each of the one or more data streams, (c) generating a prediction of whether or not a hypoglycemic event or a hyperglycemic event will occur by a prediction model based on the one or more features determined at (b), and (d) issuing an alert to the user in response to the prediction generated at (c) including a prediction that a hypoglycemic event or a hyperglycemic event will occur.

traducir

Systems for Determining Similarity of Sequences of Glucose Values

NºPublicación: US2022361779A1 17/11/2022

Solicitante:

DEXCOM INC [US]

Resumen de: US2022361779A1

In implementations of systems for determining a similarity of sequences of glucose values, a computing device implements a similarity system to receive input data describing a sequence of user glucose values measured by a continuous glucose monitoring (CGM) system. The similarity system computes similarity scores for a plurality of sequences of glucose values by comparing each glucose values included in the sequence of user glucose values with ever glucose value included in each sequence of the plurality of sequences. A particular sequence of glucose values that is associated with a highest similarity score is identified. The similarity system determines an externality associated with the particular sequence. The similarity system generates an indication of the externality for display in a user interface.

traducir

WEARABLE BLOOD PRESSURE BIOSENSORS, SYSTEMS AND METHODS FOR SHORT-TERM BLOOD PRESSURE PREDICTION

NºPublicación: WO2022241273A1 17/11/2022

Solicitante:

INFORMED DATA SYSTEMS INC D/B/A ONE DROP [US]

US_2022361823_PA

Resumen de: WO2022241273A1

Wearable blood pressure biosensors, systems, and methods for short-term blood pressure predictions are disclosed herein. In some embodiments, a blood pressure prediction system is configured to provide short-term predictions of average blood pressures for future time period(s) or horizon(s) (e.g., for a coming week). The system can include models trained to predict future systolic values, diastolic blood pressure values, and/or trends. The models can be trained on data related to personalized body, health, and/or physical characteristics of the user, e.g., the current or previous blood pressure, amount of sleep, heart rate, blood glucose (BG), activity, weight, etc. In some embodiments, the models can also determine whether the blood pressure of the user will change or remain relatively constant over a period/range of time.

traducir

USING MACRONUTRIENT INFORMATION TO OPTIMIZE INSULIN DOSING

NºPublicación: US2022361812A1 17/11/2022

Solicitante:

INSULET CORP [US]

EP_4086914_PA

Resumen de: US2022361812A1

The disclosed embodiments are directed to systems and methods for providing optimized, individualized bolus dosing of insulin based on a macronutrient profile of meals ingested by the patient. Optimized bolus dosing may be provided by varying the overall quantity of insulin delivered in the post-prandial window, as well as the split between a portion of the insulin delivered immediately after the meal and a portion of the insulin delivered later in the post-prandial window, based on an analysis of the macronutrient profile of the meal and the behavior of the blood glucose trace of the patient from past meals.

traducir

PORTABLE BREATH ANALYSIS DEVICE SYSTEM AND A METHOD THEREOF

Nº publicación: WO2022240376A2 17/11/2022

Solicitante:

BAHCESEHIR UNIV [TR]

Resumen de: WO2022240376A2

The present invention relates to a portable breath analysis device system and a method thereof that helps healthy nutrition and weight loss by allowing for detecting the intolerant foods by means of analyzing the respiratory gases received from the person's breath. The present invention particularly relates to a portable breath analysis device system and a method thereof that simultaneously and instantaneously measures acetone, ammonia, nitric oxide, ethanol, carbon monoxide, and hydrogen gases in the breath of a person, that allows for monitoring and regulating a person's carbohydrate (sugar), fat, and protein consumption with a computer-based method by transferring the data obtained from these measured gases to a mobile device.

traducir

Página1 de 6 nextPage por página

punteroimgVolver